AJRCCM Associate Editors

Alvar Agusti, MD, PhD, FRCPE is the Director of the Thorax Institute at Hospital Clinic in Barcelona and the Scientific Director of CIBERES, a national Spanish network of excellence for respiratory research (www.ciberes.org). His research work has focused on basic and clinical aspects of chronic obstructive pulmonary disease.

Peter Barnes is Professor of Thoracic Medicine and Head of Airway Disease at the National Heart and Lung Institute and Honorary Consultant Physician at Royal Brompton Hospital, London. His research is focussed on cellular and molecular mechanisms of asthma and COPD, understanding and developing therapies and research into biomarkers for these diseases. He is involved in multidisciplinary translational research which integrates basic science with clinical studies, thereby providing novel insights into common airway diseases.

Charles Daley, MD is Professor of Medicine at National Jewish Health and the University of Colorado Denver and Head of the Division of Mycobacterial and Respiratory Infections at National Jewish Health. His research focuses on the epidemiology of mycobacterial infections as well as the evaluation of new diagnostic tests and treatments.

Oliver Eickelberg, MD is Chairman of the Comprehensive Pneumology Center, a joint initiative of the Ludwig-Maximilians-University in Munich, the Asklepios Klinik Gauting and the Helmholtz Zentrum Munich. He also serves as director of the Institute of Lung Biology and Disease (iLBD) at the Helmholtz Zentrum Munich. His research focuses on the mechanisms of interstitial and vascular remodelling in idiopathic pulmonary fibrosis (IPF), pulmonary arterial hypertension (PAH), and chronic obstructive pulmonary disease (COPD).

David Gozal, MD, is Professor and Chair, Department of Pediatrics at the University of Chicago Medical Center. He is a leading expert in the treatment of pediatric sleep disorders, the developmental neurobiology of respiratory control, and sleep-disordered breathing. He is known as a pioneer in the study of childhood sleep problems, and the relationships between sleep disorders and neurobehavioral, cardiovascular, and metabolic disease. Dr. Gozal's research focuses on translational, or "bench to bedside," approaches to pediatric sleep disorders, such as childhood obstructive sleep apnea and sudden infant death syndrome (SIDS).

Tina Hartert, MD, MPH, is an Associate Professor of Medicine, Director of the Center for Asthma & Environmental Health Sciences Research, as well as the co-PI/Director of the NIEHS K12 Vanderbilt Environmental Health Science Scholars Program, and the Vanderbilt Medical Scholars Program. Dr. Hartert’s work focuses on prevention and management of the most acute and common chronic diseases of childhood worldwide: respiratory infections, asthma, and allergic diseases.

Naftali Kaminski, MD is Director of the Dorothy P. & Richard P. Simmons Center for Interstitial Lung Disease and the Lung, Blood and Vascular Center for Genomic Medicine in the Division of Pulmonary, Allergy and Critical Care Medicine, and is the Dorothy P. and Richard P. Simmons endowed chair for Pulmonary Research at the University of Pittsburgh School of Medicine. He is an internationally renowned expert in genomics of lung disease, biomarker discovery and pulmonary fibrosis.

Jay Kolls, MD, is Professor of Pediatrics and Immunology and the Director of the Richard King Mellon Foundation Institute for Pediatric Research at the University of Pittsburgh School of Medicine. His research focuses on mechanisms of lung host defenses, gene therapy, lung immunology, pneumonia, and molecular biology.

Bruce Levy, MD is a faculty member of the Pulmonary and Critical Care Medicine Division at Brigham and Women’s Hospital. His clinical interests include diseases characterized by lung inflammation or injury, such as severe asthma, COPD, sarcoidosis and other forms of interstitial lung disease, and ARDS. Dr. Levy also serves the Department of Medicine as the Residency Director for Academics and Career Development. In this role, Dr. Levy’s research focuses on the roles of endogenous counter-regulatory mediators in the lung.

Gökhan M. Mutlu, MD is an Associate Professor of Medicine in the division of Pulmonary and Critical Care Medicine at Northwestern University. His research work focuses on understanding the role of beta-adrenergic receptors in acute lung injury and in air pollution induced cardiovascular disease.

Masaharu Nishimura, MD is Professor and Chairman of the First Department of Medicine at the Hokkaido University School of Medicine in Sapporo, Japan. Dr. Nishimura’s research began with the study of breathing control, but later shifted to focus on mechanisms and clinical aspects of COPD and asthma, with a particular interest in the structure and function of these diseases.

Moisés Selman, MD is Director of Research at the National Institute of Respiratory Diseases in México, and Professor of the National Autonomous University of México. His research work has focused on the field of the interstitial lung diseases and the mechanisms involved in the fibrotic response.

B. Taylor Thompson, MD is an Associate Professor of Medicine at Harvard Medical School and the Director of the Medical Intensive Care Unit at Massachusetts General Hospital. His recent research work has focused on the design, conduct, and analysis of clinical trials of Acute Lung Injury and sepsis and on the molecular epidemiology of ARDS.

Keith Walley, MD is Professor of Critical Care Medicine at the University of British Columbia and is Associate Director of the ICU at St. Paul's Hospital. He investigates the underlying causes of cardiac and other organ dysfunction during sepsis. His research also involves studies of the genetic determinants of outcome from critical illness.